NCT00004101View on ClinicalTrials.gov

Monoclonal Antibody Therapy in Treating Patients With Recurrent Non-Hodgkin's Lymphoma

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

November 30, 1999

Primary Completion Date

June 30, 2005

Conditions
Lymphoma
Interventions
BIOLOGICAL

apolizumab

Trial Locations (5)

10021

New York Presbyterian Hospital - Cornell Campus, New York

21231

Johns Hopkins Oncology Center, Baltimore

52242

University of Iowa Hospitals and Clinics, Iowa City

20307-5000

Walter Reed Army Medical Center, Washington D.C.

20892-9903

Biologics Evaluation Section, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH